Global Continuous Glucose Monitoring Devices Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 283605
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Continuous Glucose Monitoring Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Continuous Glucose Monitoring Devices market size is estimated to be worth US$ 12690 million in 2021 and is forecast to a readjusted size of USD 20650 million by 2028 with a CAGR of 7.2% during review period. Diabetic Patients accounting for % of the Continuous Glucose Monitoring Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sensors segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Continuous Glucose Monitoring Devices include Abbott Laboratories, Echo Therapeutics, Inc., Dexcom, Inc., GlySens Incorporated, and Medtronic plc, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Continuous Glucose Monitoring Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Sensors

Transmitters & Receivers

Insulin Pumps

Market segment by Application, can be divided into

Diabetic Patients

Healthy Individuals

Market segment by players, this report covers

Abbott Laboratories

Echo Therapeutics, Inc.

Dexcom, Inc.

GlySens Incorporated

Medtronic plc

Senseonics Holdings, Inc.

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

AgaMatrix, Inc.

Glucovation

GlySure

Arkray USA, Inc.

OrSense

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Continuous Glucose Monitoring Devices product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Continuous Glucose Monitoring Devices, with revenue, gross margin and global market share of Continuous Glucose Monitoring Devices from 2019 to 2022.

Chapter 3, the Continuous Glucose Monitoring Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Continuous Glucose Monitoring Devices market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Continuous Glucose Monitoring Devices research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Continuous Glucose Monitoring Devices

1.2 Classification of Continuous Glucose Monitoring Devices by Type

1.2.1 Overview: Global Continuous Glucose Monitoring Devices Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Type in 2021

1.2.3 Sensors

1.2.4 Transmitters & Receivers

1.2.5 Insulin Pumps

1.3 Global Continuous Glucose Monitoring Devices Market by Application

1.3.1 Overview: Global Continuous Glucose Monitoring Devices Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Diabetic Patients

1.3.3 Healthy Individuals

1.4 Global Continuous Glucose Monitoring Devices Market Size & Forecast

1.5 Global Continuous Glucose Monitoring Devices Market Size and Forecast by Region

1.5.1 Global Continuous Glucose Monitoring Devices Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Continuous Glucose Monitoring Devices Market Size by Region, (2017-2022)

1.5.3 North America Continuous Glucose Monitoring Devices Market Size and Prospect (2017-2028)

1.5.4 Europe Continuous Glucose Monitoring Devices Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Continuous Glucose Monitoring Devices Market Size and Prospect (2017-2028)

1.5.6 South America Continuous Glucose Monitoring Devices Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Continuous Glucose Monitoring Devices Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Continuous Glucose Monitoring Devices Market Drivers

1.6.2 Continuous Glucose Monitoring Devices Market Restraints

1.6.3 Continuous Glucose Monitoring Devices Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Product and Solutions

2.1.4 Abbott Laboratories Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Echo Therapeutics, Inc.

2.2.1 Echo Therapeutics, Inc. Details

2.2.2 Echo Therapeutics, Inc. Major Business

2.2.3 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Product and Solutions

2.2.4 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Echo Therapeutics, Inc. Recent Developments and Future Plans

2.3 Dexcom, Inc.

2.3.1 Dexcom, Inc. Details

2.3.2 Dexcom, Inc. Major Business

2.3.3 Dexcom, Inc. Continuous Glucose Monitoring Devices Product and Solutions

2.3.4 Dexcom, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Dexcom, Inc. Recent Developments and Future Plans

2.4 GlySens Incorporated

2.4.1 GlySens Incorporated Details

2.4.2 GlySens Incorporated Major Business

2.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Product and Solutions

2.4.4 GlySens Incorporated Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GlySens Incorporated Recent Developments and Future Plans

2.5 Medtronic plc

2.5.1 Medtronic plc Details

2.5.2 Medtronic plc Major Business

2.5.3 Medtronic plc Continuous Glucose Monitoring Devices Product and Solutions

2.5.4 Medtronic plc Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Medtronic plc Recent Developments and Future Plans

2.6 Senseonics Holdings, Inc.

2.6.1 Senseonics Holdings, Inc. Details

2.6.2 Senseonics Holdings, Inc. Major Business

2.6.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Product and Solutions

2.6.4 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Senseonics Holdings, Inc. Recent Developments and Future Plans

2.7 Johnson & Johnson

2.7.1 Johnson & Johnson Details

2.7.2 Johnson & Johnson Major Business

2.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Product and Solutions

2.7.4 Johnson & Johnson Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Johnson & Johnson Recent Developments and Future Plans

2.8 F. Hoffmann-La Roche Ltd.

2.8.1 F. Hoffmann-La Roche Ltd. Details

2.8.2 F. Hoffmann-La Roche Ltd. Major Business

2.8.3 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Product and Solutions

2.8.4 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

2.9 AgaMatrix, Inc.

2.9.1 AgaMatrix, Inc. Details

2.9.2 AgaMatrix, Inc. Major Business

2.9.3 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Product and Solutions

2.9.4 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 AgaMatrix, Inc. Recent Developments and Future Plans

2.10 Glucovation

2.10.1 Glucovation Details

2.10.2 Glucovation Major Business

2.10.3 Glucovation Continuous Glucose Monitoring Devices Product and Solutions

2.10.4 Glucovation Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Glucovation Recent Developments and Future Plans

2.11 GlySure

2.11.1 GlySure Details

2.11.2 GlySure Major Business

2.11.3 GlySure Continuous Glucose Monitoring Devices Product and Solutions

2.11.4 GlySure Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 GlySure Recent Developments and Future Plans

2.12 Arkray USA, Inc.

2.12.1 Arkray USA, Inc. Details

2.12.2 Arkray USA, Inc. Major Business

2.12.3 Arkray USA, Inc. Continuous Glucose Monitoring Devices Product and Solutions

2.12.4 Arkray USA, Inc. Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Arkray USA, Inc. Recent Developments and Future Plans

2.13 OrSense

2.13.1 OrSense Details

2.13.2 OrSense Major Business

2.13.3 OrSense Continuous Glucose Monitoring Devices Product and Solutions

2.13.4 OrSense Continuous Glucose Monitoring Devices Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 OrSense Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Continuous Glucose Monitoring Devices Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Continuous Glucose Monitoring Devices Players Market Share in 2021

3.2.2 Top 10 Continuous Glucose Monitoring Devices Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Continuous Glucose Monitoring Devices Players Head Office, Products and Services Provided

3.4 Continuous Glucose Monitoring Devices Mergers & Acquisitions

3.5 Continuous Glucose Monitoring Devices New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Continuous Glucose Monitoring Devices Revenue and Market Share by Type (2017-2022)

4.2 Global Continuous Glucose Monitoring Devices Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Continuous Glucose Monitoring Devices Revenue Market Share by Application (2017-2022)

5.2 Global Continuous Glucose Monitoring Devices Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Continuous Glucose Monitoring Devices Revenue by Type (2017-2028)

6.2 North America Continuous Glucose Monitoring Devices Revenue by Application (2017-2028)

6.3 North America Continuous Glucose Monitoring Devices Market Size by Country

6.3.1 North America Continuous Glucose Monitoring Devices Revenue by Country (2017-2028)

6.3.2 United States Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

6.3.3 Canada Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

6.3.4 Mexico Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Continuous Glucose Monitoring Devices Revenue by Type (2017-2028)

7.2 Europe Continuous Glucose Monitoring Devices Revenue by Application (2017-2028)

7.3 Europe Continuous Glucose Monitoring Devices Market Size by Country

7.3.1 Europe Continuous Glucose Monitoring Devices Revenue by Country (2017-2028)

7.3.2 Germany Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

7.3.3 France Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

7.3.5 Russia Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

7.3.6 Italy Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Type (2017-2028)

8.2 Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Application (2017-2028)

8.3 Asia-Pacific Continuous Glucose Monitoring Devices Market Size by Region

8.3.1 Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Region (2017-2028)

8.3.2 China Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8.3.3 Japan Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8.3.4 South Korea Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8.3.5 India Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

8.3.7 Australia Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Continuous Glucose Monitoring Devices Revenue by Type (2017-2028)

9.2 South America Continuous Glucose Monitoring Devices Revenue by Application (2017-2028)

9.3 South America Continuous Glucose Monitoring Devices Market Size by Country

9.3.1 South America Continuous Glucose Monitoring Devices Revenue by Country (2017-2028)

9.3.2 Brazil Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

9.3.3 Argentina Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Type (2017-2028)

10.2 Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Application (2017-2028)

10.3 Middle East & Africa Continuous Glucose Monitoring Devices Market Size by Country

10.3.1 Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Country (2017-2028)

10.3.2 Turkey Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

10.3.4 UAE Continuous Glucose Monitoring Devices Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Continuous Glucose Monitoring Devices Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Continuous Glucose Monitoring Devices Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Continuous Glucose Monitoring Devices Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Continuous Glucose Monitoring Devices Revenue (USD Million) by Region (2017-2022)

Table 5. Global Continuous Glucose Monitoring Devices Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Continuous Glucose Monitoring Devices Product and Solutions

Table 9. Abbott Laboratories Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Echo Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Echo Therapeutics, Inc. Major Business

Table 12. Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Product and Solutions

Table 13. Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Dexcom, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Dexcom, Inc. Major Business

Table 16. Dexcom, Inc. Continuous Glucose Monitoring Devices Product and Solutions

Table 17. Dexcom, Inc. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GlySens Incorporated Corporate Information, Head Office, and Major Competitors

Table 19. GlySens Incorporated Major Business

Table 20. GlySens Incorporated Continuous Glucose Monitoring Devices Product and Solutions

Table 21. GlySens Incorporated Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Medtronic plc Corporate Information, Head Office, and Major Competitors

Table 23. Medtronic plc Major Business

Table 24. Medtronic plc Continuous Glucose Monitoring Devices Product and Solutions

Table 25. Medtronic plc Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Senseonics Holdings, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Senseonics Holdings, Inc. Major Business

Table 28. Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Product and Solutions

Table 29. Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 31. Johnson & Johnson Major Business

Table 32. Johnson & Johnson Continuous Glucose Monitoring Devices Product and Solutions

Table 33. Johnson & Johnson Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 35. F. Hoffmann-La Roche Ltd. Major Business

Table 36. F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Product and Solutions

Table 37. F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. AgaMatrix, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. AgaMatrix, Inc. Major Business

Table 40. AgaMatrix, Inc. Continuous Glucose Monitoring Devices Product and Solutions

Table 41. AgaMatrix, Inc. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Glucovation Corporate Information, Head Office, and Major Competitors

Table 43. Glucovation Major Business

Table 44. Glucovation Continuous Glucose Monitoring Devices Product and Solutions

Table 45. Glucovation Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. GlySure Corporate Information, Head Office, and Major Competitors

Table 47. GlySure Major Business

Table 48. GlySure Continuous Glucose Monitoring Devices Product and Solutions

Table 49. GlySure Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Arkray USA, Inc. Corporate Information, Head Office, and Major Competitors

Table 51. Arkray USA, Inc. Major Business

Table 52. Arkray USA, Inc. Continuous Glucose Monitoring Devices Product and Solutions

Table 53. Arkray USA, Inc. Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. OrSense Corporate Information, Head Office, and Major Competitors

Table 55. OrSense Major Business

Table 56. OrSense Continuous Glucose Monitoring Devices Product and Solutions

Table 57. OrSense Continuous Glucose Monitoring Devices Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Continuous Glucose Monitoring Devices Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Continuous Glucose Monitoring Devices Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Continuous Glucose Monitoring Devices by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Continuous Glucose Monitoring Devices Players Head Office, Products and Services Provided

Table 62. Continuous Glucose Monitoring Devices Mergers & Acquisitions in the Past Five Years

Table 63. Continuous Glucose Monitoring Devices New Entrants and Expansion Plans

Table 64. Global Continuous Glucose Monitoring Devices Revenue (USD Million) by Type (2017-2022)

Table 65. Global Continuous Glucose Monitoring Devices Revenue Share by Type (2017-2022)

Table 66. Global Continuous Glucose Monitoring Devices Revenue Forecast by Type (2023-2028)

Table 67. Global Continuous Glucose Monitoring Devices Revenue by Application (2017-2022)

Table 68. Global Continuous Glucose Monitoring Devices Revenue Forecast by Application (2023-2028)

Table 69. North America Continuous Glucose Monitoring Devices Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Continuous Glucose Monitoring Devices Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Continuous Glucose Monitoring Devices Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Continuous Glucose Monitoring Devices Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Continuous Glucose Monitoring Devices Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Continuous Glucose Monitoring Devices Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Continuous Glucose Monitoring Devices Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Continuous Glucose Monitoring Devices Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Continuous Glucose Monitoring Devices Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Continuous Glucose Monitoring Devices Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Continuous Glucose Monitoring Devices Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Continuous Glucose Monitoring Devices Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Continuous Glucose Monitoring Devices Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Continuous Glucose Monitoring Devices Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Continuous Glucose Monitoring Devices Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Continuous Glucose Monitoring Devices Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Continuous Glucose Monitoring Devices Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Continuous Glucose Monitoring Devices Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Continuous Glucose Monitoring Devices Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Continuous Glucose Monitoring Devices Picture

Figure 2. Global Continuous Glucose Monitoring Devices Revenue Market Share by Type in 2021

Figure 3. Sensors

Figure 4. Transmitters & Receivers

Figure 5. Insulin Pumps

Figure 6. Continuous Glucose Monitoring Devices Revenue Market Share by Application in 2021

Figure 7. Diabetic Patients Picture

Figure 8. Healthy Individuals Picture

Figure 9. Global Continuous Glucose Monitoring Devices Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Continuous Glucose Monitoring Devices Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Continuous Glucose Monitoring Devices Revenue Market Share by Region (2017-2028)

Figure 12. Global Continuous Glucose Monitoring Devices Revenue Market Share by Region in 2021

Figure 13. North America Continuous Glucose Monitoring Devices Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Continuous Glucose Monitoring Devices Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Continuous Glucose Monitoring Devices Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Continuous Glucose Monitoring Devices Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Continuous Glucose Monitoring Devices Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Continuous Glucose Monitoring Devices Market Drivers

Figure 19. Continuous Glucose Monitoring Devices Market Restraints

Figure 20. Continuous Glucose Monitoring Devices Market Trends

Figure 21. Abbott Laboratories Recent Developments and Future Plans

Figure 22. Echo Therapeutics, Inc. Recent Developments and Future Plans

Figure 23. Dexcom, Inc. Recent Developments and Future Plans

Figure 24. GlySens Incorporated Recent Developments and Future Plans

Figure 25. Medtronic plc Recent Developments and Future Plans

Figure 26. Senseonics Holdings, Inc. Recent Developments and Future Plans

Figure 27. Johnson & Johnson Recent Developments and Future Plans

Figure 28. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

Figure 29. AgaMatrix, Inc. Recent Developments and Future Plans

Figure 30. Glucovation Recent Developments and Future Plans

Figure 31. GlySure Recent Developments and Future Plans

Figure 32. Arkray USA, Inc. Recent Developments and Future Plans

Figure 33. OrSense Recent Developments and Future Plans

Figure 34. Global Continuous Glucose Monitoring Devices Revenue Share by Players in 2021

Figure 35. Continuous Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Continuous Glucose Monitoring Devices Revenue Market Share in 2021

Figure 37. Global Top 10 Players Continuous Glucose Monitoring Devices Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Continuous Glucose Monitoring Devices Revenue Share by Type in 2021

Figure 40. Global Continuous Glucose Monitoring Devices Market Share Forecast by Type (2023-2028)

Figure 41. Global Continuous Glucose Monitoring Devices Revenue Share by Application in 2021

Figure 42. Global Continuous Glucose Monitoring Devices Market Share Forecast by Application (2023-2028)

Figure 43. North America Continuous Glucose Monitoring Devices Sales Market Share by Type (2017-2028)

Figure 44. North America Continuous Glucose Monitoring Devices Sales Market Share by Application (2017-2028)

Figure 45. North America Continuous Glucose Monitoring Devices Revenue Market Share by Country (2017-2028)

Figure 46. United States Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Continuous Glucose Monitoring Devices Sales Market Share by Type (2017-2028)

Figure 50. Europe Continuous Glucose Monitoring Devices Sales Market Share by Application (2017-2028)

Figure 51. Europe Continuous Glucose Monitoring Devices Revenue Market Share by Country (2017-2028)

Figure 52. Germany Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Continuous Glucose Monitoring Devices Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Continuous Glucose Monitoring Devices Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Continuous Glucose Monitoring Devices Revenue Market Share by Region (2017-2028)

Figure 60. China Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Continuous Glucose Monitoring Devices Sales Market Share by Type (2017-2028)

Figure 67. South America Continuous Glucose Monitoring Devices Sales Market Share by Application (2017-2028)

Figure 68. South America Continuous Glucose Monitoring Devices Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Continuous Glucose Monitoring Devices Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Continuous Glucose Monitoring Devices Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Continuous Glucose Monitoring Devices Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Continuous Glucose Monitoring Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source